Skip to main content
. 2013 Jun 21;7:519–527. doi: 10.2147/DDDT.S31442

Figure 1.

Figure 1

Schema for Phase II tivozanib trial.

Abbreviations: ccRCC, clear cell renal cell carcinoma; ECOG, Eastern Cooperative Oncology Group (performance score); ORR, objective response rate; PFS, progression-free survival; R, randomized; VEGF, vascular endothelial growth factor.